Promoter selection is of utmost importance for the study of in vivo gene function using transgenic models. In the present study, we have analyzed the expression of the GFP marker under the control of the composite CAG promoter in the lymphoid compartment of several transgenic mouse strains. Despite the ability of the CAG promoter to drive gene expression in almost all tissues examined to date, its activity appears to be developmentally regulated within the T lymphocyte cell lineage. In particular, CD4 and CD8-expressing, thymic immature T cells displayed lower levels of the GFP marker when compared with both bone marrow precursors and mature circulating T cells, suggesting a transient downregulation of CAG activity during T cell development. Alternative promoters may therefore be preferred for the study of T cell development in vivo using a transgenic approach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/dvg.20569 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimizing approaches for targeted integration of transgenic cassettes by integrase-mediated cassette exchange in mouse and human stem cells.
Stem Cells
January 2025
Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom.
To enable robust expression of transgenes in stem cells, recombinase-mediated cassette exchange at safe harbor loci is frequently adopted. The choice of recombinase enzyme is a critical parameter to ensure maximum efficiency and accuracy of the integration event. We have explored the serine recombinase family of site-specific integrases and have directly compared the efficiency of PhiC31, W-beta, and Bxb1 integrase for targeted transgene integration at the Gt(ROSA)26Sor locus in mouse embryonic stem cells.
View Article and Find Full Text PDFOligodendrocytes, the Forgotten Target of Gene Therapy.
Cells
November 2024
MIRCen Institute, Laboratoire des Maladies Neurodégénératives, Commissariat à l'Energie Atomique, 92260 Fontenay-aux-Roses, France.
If the billions of oligodendrocytes (OLs) populating the central nervous system (CNS) of patients could express their feelings, they would undoubtedly tell gene therapists about their frustration with the other neural cell populations, neurons, microglia, or astrocytes, which have been the favorite targets of gene transfer experiments. This review questions why OLs have been left out of most gene therapy attempts. The first explanation is that the pathogenic role of OLs is still discussed in most CNS diseases.
View Article and Find Full Text PDFEnhanced design of pCMViR-TSC plasmid vector for sustainably high cargo gene expression in mammalian cells.
In Vitro Cell Dev Biol Anim
December 2024
Faculty of Science and Technology, Division of Molecular Science, Gunma University, Kiryu, Gunma, Japan.
Article Synopsis
- The first-generation vector pCMViR-TSC shows significantly higher gene expression (10- to 100-fold) compared to standard plasmids but is limited to transient gene expression in mammalian cells.
- To address this limitation, a new second-generation vector, pSAKA-4B, is introduced, enabling stable integration of genes into mammalian DNA with high efficiency.
- This improved vector system allows for indefinite gene expression, making it valuable for basic research and potential clinical applications like gene therapy.
Prrx1-driven LINC complex disruption in vivo reduces osteoid deposition but not bone quality after voluntary wheel running.
PLoS One
November 2024
Mechanical and Biomedical Engineering, Boise State University, Boise, Idaho, United States of America.
The Linker of Nucleoskeleton and Cytoskeleton (LINC) complex serves to connect the nuclear envelope and the cytoskeleton, influencing cellular processes such as nuclear arrangement, architecture, and mechanotransduction. The role LINC plays in mechanotransduction pathways in bone progenitor cells has been well studied; however, the mechanisms by which LINC complexes govern in vivo bone formation remain less clear. To bridge this knowledge gap, we established a murine model disrupting LINC using transgenic Prx-Cre mice and floxed Tg(CAG-LacZ/EGFP-KASH2) mice.
View Article and Find Full Text PDFOptimal different adeno-associated virus capsid/promoter combinations to target specific cell types in the common marmoset cerebral cortex.
Mol Ther Methods Clin Dev
December 2024
Department of Neurophysiology & Neural Repair, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.
Article Synopsis
- To enhance gene expression in specific brain cell types, researchers tested nine different adeno-associated virus (AAV) capsids in marmoset cerebral cortical cells.
- AAV9 and AAVrh10 showed strong neuron-selective gene expression, while AAV5 primarily affected oligodendrocytes, especially with certain promoters.
- The study identified optimal capsid and promoter pairings for targeted expression: AAV9/AAVrh10 with ubiquitous CBh/CMV for neurons, AAV2/AAV7 with hGFA(ABC1D) for astrocytes, and AAV5 with mMBP for oligodendrocytes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!